134 related articles for article (PubMed ID: 29032929)
21. Rational drug design in parasitology: trans-sialidase as a case study for Chagas disease.
Neres J; Bryce RA; Douglas KT
Drug Discov Today; 2008 Feb; 13(3-4):110-7. PubMed ID: 18275908
[TBL] [Abstract][Full Text] [Related]
22. Continuous nonradioactive method for screening trypanosomal trans-sialidase activity and its inhibitors.
Sartor PA; Agusti R; Leguizamón MS; Campetella O; de Lederkremer RM
Glycobiology; 2010 Aug; 20(8):982-90. PubMed ID: 20375068
[TBL] [Abstract][Full Text] [Related]
23. Molecular Design, Synthesis and Trypanocidal Activity of Dipeptidyl Nitriles as Cruzain Inhibitors.
Avelar LA; Camilo CD; de Albuquerque S; Fernandes WB; Gonçalez C; Kenny PW; Leitão A; McKerrow JH; Montanari CA; Orozco EV; Ribeiro JF; Rocha JR; Rosini F; Saidel ME
PLoS Negl Trop Dis; 2015; 9(7):e0003916. PubMed ID: 26173110
[TBL] [Abstract][Full Text] [Related]
24. Synthetic 1,2,3-triazole-linked glycoconjugates bind with high affinity to human galectin-3.
Marchiori MF; Souto DE; Bortot LO; Pereira JF; Kubota LT; Cummings RD; Dias-Baruffi M; Carvalho I; Campo VL
Bioorg Med Chem; 2015 Jul; 23(13):3414-25. PubMed ID: 25975642
[TBL] [Abstract][Full Text] [Related]
25. Development of bis-thiazoles as inhibitors of triosephosphate isomerase from Trypanosoma cruzi. Identification of new non-mutagenic agents that are active in vivo.
Álvarez G; Martínez J; Varela J; Birriel E; Cruces E; Gabay M; Leal SM; Escobar P; Aguirre-López B; Cabrera N; Tuena de Gómez-Puyou M; Gómez Puyou A; Pérez-Montfort R; Yaluff G; Torres S; Serna E; Vera de Bilbao N; González M; Cerecetto H
Eur J Med Chem; 2015 Jul; 100():246-56. PubMed ID: 26094151
[TBL] [Abstract][Full Text] [Related]
26. Synthesis and structure-activity relationship study of a new series of antiparasitic aryloxyl thiosemicarbazones inhibiting Trypanosoma cruzi cruzain.
Espíndola JW; Cardoso MV; Filho GB; Oliveira E Silva DA; Moreira DR; Bastos TM; Simone CA; Soares MB; Villela FS; Ferreira RS; Castro MC; Pereira VR; Murta SM; Sales Junior PA; Romanha AJ; Leite AC
Eur J Med Chem; 2015 Aug; 101():818-35. PubMed ID: 26231082
[TBL] [Abstract][Full Text] [Related]
27. Structure-activity relationships in 2-aminodiphenylsulfides against trypanothione reductase from Trypanosoma cruzi.
Girault S; Davioud-Charvet E; Salmon L; Berecibar A; Debreu MA; Sergheraert C
Bioorg Med Chem Lett; 1998 May; 8(10):1175-80. PubMed ID: 9871730
[TBL] [Abstract][Full Text] [Related]
28. A new class of mechanism-based inhibitors for Trypanosoma cruzi trans-sialidase and their influence on parasite virulence.
Carvalho ST; Sola-Penna M; Oliveira IA; Pita S; Gonçalves AS; Neves BC; Sousa FR; Freire-de-Lima L; Kurogochi M; Hinou H; Nishimura S; Mendonça-Previato L; Previato JO; Todeschini AR
Glycobiology; 2010 Aug; 20(8):1034-45. PubMed ID: 20466651
[TBL] [Abstract][Full Text] [Related]
29. Sialic acid C-glycosides with aromatic residues: investigating enzyme binding and inhibition of Trypanosoma cruzi trans-sialidase.
Meinke S; Schroven A; Thiem J
Org Biomol Chem; 2011 Jun; 9(12):4487-97. PubMed ID: 21528140
[TBL] [Abstract][Full Text] [Related]
30. Synthesis of PEGylated lactose analogs for inhibition studies on T.cruzi trans-sialidase.
Giorgi ME; Ratier L; Agusti R; Frasch AC; de Lederkremer RM
Glycoconj J; 2010 Jul; 27(5):549-59. PubMed ID: 20645127
[TBL] [Abstract][Full Text] [Related]
31. Novel 3-nitro-1H-1,2,4-triazole-based amides and sulfonamides as potential antitrypanosomal agents.
Papadopoulou MV; Bloomer WD; Rosenzweig HS; Chatelain E; Kaiser M; Wilkinson SR; McKenzie C; Ioset JR
J Med Chem; 2012 Jun; 55(11):5554-65. PubMed ID: 22550999
[TBL] [Abstract][Full Text] [Related]
32. On the search for potential anti-Trypanosoma cruzi drugs: synthesis and biological evaluation of 2-hydroxy-3-methylamino and 1,2,3-triazolic naphthoquinoidal compounds obtained by click chemistry reactions.
da Silva Júnior EN; de Melo IM; Diogo EB; Costa VA; de Souza Filho JD; Valença WO; Camara CA; de Oliveira RN; de Araujo AS; Emery FS; dos Santos MR; de Simone CA; Menna-Barreto RF; de Castro SL
Eur J Med Chem; 2012 Jun; 52():304-12. PubMed ID: 22483633
[TBL] [Abstract][Full Text] [Related]
33. Synthesis and Antitrypanosomal Activity of 1,4-Disubstituted Triazole Compounds Based on a 2-Nitroimidazole Scaffold: a Structure-Activity Relationship Study.
Assunção ELF; Carvalho DB; das Neves AR; Kawasoko Shiguemotto CY; Portapilla GB; de Albuquerque S; Baroni ACM
ChemMedChem; 2020 Nov; 15(21):2019-2028. PubMed ID: 32729242
[TBL] [Abstract][Full Text] [Related]
34. Synthesis and in vitro evaluation of leishmanicidal and trypanocidal activities of N-quinolin-8-yl-arylsulfonamides.
da Silva LE; Joussef AC; Pacheco LK; da Silva DG; Steindel M; Rebelo RA; Schmidt B
Bioorg Med Chem; 2007 Dec; 15(24):7553-60. PubMed ID: 17889546
[TBL] [Abstract][Full Text] [Related]
35. Trypanosoma cruzi trans-sialidase alternative substrates: Study of the effect of substitution in C-6 in benzyl β-lactoside.
Morrone-Pozzuto P; Uhrig ML; Agusti R
Carbohydr Res; 2019 May; 478():33-45. PubMed ID: 31054381
[TBL] [Abstract][Full Text] [Related]
36. Efficient identification of inhibitors targeting the closed active site conformation of the HPRT from Trypanosoma cruzi.
Freymann DM; Wenck MA; Engel JC; Feng J; Focia PJ; Eakin AE; Craig SP
Chem Biol; 2000 Dec; 7(12):957-68. PubMed ID: 11137818
[TBL] [Abstract][Full Text] [Related]
37. Lactose derivatives are inhibitors of Trypanosoma cruzi trans-sialidase activity toward conventional substrates in vitro and in vivo.
Agustí R; París G; Ratier L; Frasch AC; de Lederkremer RM
Glycobiology; 2004 Jul; 14(7):659-70. PubMed ID: 15070857
[TBL] [Abstract][Full Text] [Related]
38. Expanding the binding envelope of CYP51 inhibitors targeting Trypanosoma cruzi with 4-aminopyridyl-based sulfonamide derivatives.
Vieira DF; Choi JY; Roush WR; Podust LM
Chembiochem; 2014 May; 15(8):1111-20. PubMed ID: 24771705
[TBL] [Abstract][Full Text] [Related]
39. Structural design, synthesis and pharmacological evaluation of thiazoles against Trypanosoma cruzi.
de Oliveira Filho GB; Cardoso MVO; Espíndola JWP; Oliveira E Silva DA; Ferreira RS; Coelho PL; Anjos PSD; Santos ES; Meira CS; Moreira DRM; Soares MBP; Leite ACL
Eur J Med Chem; 2017 Dec; 141():346-361. PubMed ID: 29031078
[TBL] [Abstract][Full Text] [Related]
40. Effect of 4-amino-3-nitrobenzoic acid on the expression level of the trans-sialidase gene in Trypanosoma cruzi epimastigotes.
Vázquez-Jiménez LK; Paz-González AD; Kashif M; Juárez-Rendón KJ; Nogueda-Torres B; Bocanegra-García V; Rivera G
Pak J Pharm Sci; 2019 Mar; 32(2 (Supplementary)):825-829. PubMed ID: 31103978
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
